Shlomo Keidar

3.5k total citations
61 papers, 2.9k citations indexed

About

Shlomo Keidar is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Shlomo Keidar has authored 61 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Surgery, 25 papers in Cardiology and Cardiovascular Medicine and 20 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Shlomo Keidar's work include Cardiovascular, Neuropeptides, and Oxidative Stress Research (17 papers), Hormonal Regulation and Hypertension (16 papers) and Lipoproteins and Cardiovascular Health (15 papers). Shlomo Keidar is often cited by papers focused on Cardiovascular, Neuropeptides, and Oxidative Stress Research (17 papers), Hormonal Regulation and Hypertension (16 papers) and Lipoproteins and Cardiovascular Health (15 papers). Shlomo Keidar collaborates with scholars based in Israel, United States and Italy. Shlomo Keidar's co-authors include Michael Aviram, Tony Hayek, Marielle Kaplan, Raymond Coleman, Judith Attias, Mira Rosenblat, Shadi Hamoud, Elsa Pavlotzky, Ronit Heinrich and Aviva Gamliel-Lazarovich and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Circulation Research.

In The Last Decade

Shlomo Keidar

60 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shlomo Keidar Israel	27	1.1k	1.0k	957	503	458	61	2.9k
Anselm T. Bäumer Germany	18	965 0.9×	768 0.8×	772 0.8×	656 1.3×	312 0.7×	29	2.7k
Gabriele Bittolo Bon Italy	20	451 0.4×	902 0.9×	870 0.9×	304 0.6×	293 0.6×	43	2.3k
Baichun Yang United States	25	664 0.6×	366 0.4×	981 1.0×	853 1.7×	362 0.8×	53	3.3k
S. Colli Italy	28	597 0.5×	857 0.8×	320 0.3×	545 1.1×	440 1.0×	104	2.7k
P Avogaro Italy	22	525 0.5×	1.5k 1.4×	1.2k 1.3×	428 0.9×	495 1.1×	69	2.8k
G. Cazzolato Italy	25	542 0.5×	1.6k 1.6×	1.4k 1.4×	539 1.1×	606 1.3×	69	3.4k
Ulisse Garbin Italy	36	714 0.7×	569 0.6×	515 0.5×	1.0k 2.0×	1.1k 2.4×	79	3.8k
Ludovica Piconi Italy	20	1.1k 1.0×	696 0.7×	2.3k 2.4×	837 1.7×	231 0.5×	25	4.3k
Eak Kyun Shin South Korea	31	1.3k 1.2×	1.3k 1.3×	1.1k 1.2×	332 0.7×	272 0.6×	123	3.2k
Charles L. Bisgaier United States	29	423 0.4×	1.4k 1.4×	932 1.0×	1.4k 2.9×	394 0.9×	57	4.4k

Countries citing papers authored by Shlomo Keidar

Since Specialization

Citations

This map shows the geographic impact of Shlomo Keidar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shlomo Keidar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shlomo Keidar more than expected).

Fields of papers citing papers by Shlomo Keidar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shlomo Keidar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shlomo Keidar. The network helps show where Shlomo Keidar may publish in the future.

Co-authorship network of co-authors of Shlomo Keidar

This figure shows the co-authorship network connecting the top 25 collaborators of Shlomo Keidar. A scholar is included among the top collaborators of Shlomo Keidar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shlomo Keidar. Shlomo Keidar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Keidar, Shlomo & Aviva Gamliel-Lazarovich. (2013). Viewpoint: Personalizing Statin Therapy. SHILAP Revista de lepidopterología. 4(2). e0008–e0008.

Gamliel-Lazarovich, Aviva, Ayelet Raz‐Pasteur, Raymond Coleman, & Shlomo Keidar. (2013). The effects of aldosterone on diet-induced fatty liver formation in male C57BL/6 mice. European Journal of Gastroenterology & Hepatology. 25(9). 1086–1092. 13 indexed citations

Gamliel-Lazarovich, Aviva, Zaid Abassi, Soliman Khatib, et al.. (2012). Paraoxonase1 deficiency in mice is associated with hypotension and increased levels of 5,6-epoxyeicosatrienoic acid. Atherosclerosis. 222(1). 92–98. 18 indexed citations

Gamliel-Lazarovich, Aviva, Anna Gantman, Raymond Coleman, et al.. (2010). FAD286, an aldosterone synthase inhibitor, reduced atherosclerosis and inflammation in apolipoprotein E-deficient mice. Journal of Hypertension. 28(9). 1900–1907. 21 indexed citations

Gamliel-Lazarovich, Aviva, Anna Gantman, Maayan Shiner, et al.. (2010). Paraoxonase 1 deficiency in mice is associated with reduced steroid biosynthesis: Effects on HDL binding, cholesteryl ester accumulation and scavenger receptor type BI expression. Atherosclerosis. 211(1). 130–135. 3 indexed citations

Bonomini, Francesca, Francesca Filippini, Tony Hayek, et al.. (2009). Apolipoprotein E and its role in aging and survival. Experimental Gerontology. 45(2). 149–157. 48 indexed citations

Limor, Rona, Marielle Kaplan, Orly Sharon, et al.. (2009). Aldosterone up‐regulates 12‐ and 15‐lipoxygenase expression and LDL oxidation in human vascular smooth muscle cells. Journal of Cellular Biochemistry. 108(5). 1203–1210. 18 indexed citations

Keidar, Shlomo, et al.. (2009). High plasma high-density lipoprotein levels, very low cardiovascular risk profile, and subclinical carotid atherosclerosis in postmenopausal women. Journal of clinical lipidology. 3(5). 345–350. 18 indexed citations

Keidar, Shlomo, et al.. (2007). High incidence of reduced plasma HDL cholesterol in diabetic patients treated with rosiglitazone and fibrate. Pharmacoepidemiology and Drug Safety. 16(11). 1192–1194. 15 indexed citations

10.

Rodella, Luigi Fabrizio, Francesca Bonomini, Rita Rezzani, et al.. (2006). Atherosclerosis and the protective role played by different proteins in apolipoprotein E-deficient mice. Acta Histochemica. 109(1). 45–51. 14 indexed citations

11.

Baldassarre, Damiano, Mauro Amato, S. Castelnuovo, et al.. (2006). Measurement of carotid artery intima-media thickness in dyslipidemic patients increases the power of traditional risk factors to predict cardiovascular events. Atherosclerosis. 191(2). 403–408. 65 indexed citations

12.

Karram, Tony, Shlomo Keidar, Eliahu Golomb, et al.. (2005). Effects of spironolactone and eprosartan on cardiac remodeling and angiotensin-converting enzyme isoforms in rats with experimental heart failure. American Journal of Physiology-Heart and Circulatory Physiology. 289(4). H1351–H1358. 67 indexed citations

13.

Hayek, Tony, Marielle Kaplan, Ayelet Raz, et al.. (2002). Ramipril administration to atherosclerotic mice reduces oxidized low-density lipoprotein uptake by their macrophages and blocks the progression of atherosclerosis. Atherosclerosis. 161(1). 65–74. 37 indexed citations

14.

Keidar, Shlomo, Judith Attias, Raymond Coleman, et al.. (2000). Attenuation of Atherosclerosis in Apolipoprotein E-Deficient Mice by Ramipril is Dissociated from Its Antihypertensive Effect and from Potentiation of Bradykinin. Journal of Cardiovascular Pharmacology. 35(1). 64–72. 51 indexed citations

15.

Keidar, Shlomo, Judith Attias, Ronit Heinrich, Raymond Coleman, & Michael Aviram. (1999). Angiotensin II atherogenicity in apolipoprotein E deficient mice is associated with increased cellular cholesterol biosynthesis. Atherosclerosis. 146(2). 249–257. 80 indexed citations

16.

Aviram, Michael, et al.. (1998). Interactions of Platelets, Macrophages, and Lipoproteins in Hypercholesterolemia: Antiatherogenic Effects of HMG-CoA Reductase Inhibitor Therapy. Journal of Cardiovascular Pharmacology. 31(1). 39–45. 91 indexed citations

17.

Hayek, Tony, Judith Attias, Jonathan D. Smith, Jan L. Breslow, & Shlomo Keidar. (1998). Antiatherosclerotic and Antioxidative Effects of Captopril in Apolipoprotein E-Deficient Mice. Journal of Cardiovascular Pharmacology. 31(4). 540–544. 92 indexed citations

18.

Keidar, Shlomo & Judith Attias. (1997). Angiotensin II Injection into Mice Increases the Uptake of Oxidized LDL by Their Macrophages via a Proteoglycan-Mediated Pathway. Biochemical and Biophysical Research Communications. 239(1). 63–67. 38 indexed citations

19.

Keidar, Shlomo, Judith Attias, Jonathan D. Smith, Jan L. Breslow, & Tony Hayek. (1997). The Angiotensin-II Receptor Antagonist, Losartan, Inhibits LDL Lipid Peroxidation and Atherosclerosis in Apolipoprotein E-Deficient Mice. Biochemical and Biophysical Research Communications. 236(3). 622–625. 119 indexed citations

20.

Keidar, Shlomo, Richard E. Ostlund, & Gustav Schonfeld. (1990). Apolipoprotein E-rich HDL in patients with homozygous familial hypercholesterolemia. Atherosclerosis. 84(2-3). 155–163. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact